Kawaguchi T - Search Results

1

Lack of Association Between Immunotherapy and Improvement of Survival for Non-small Cell Lung Cancer Patients With Hemodialysis: A Nationwide Retrospective Cohort Study.

Sawa K, Ihara Y, Imai T, Sugimoto A, Nagamine H, Ogawa K, Nakahama K, Matsumoto Y, Tani Y, Kaneda H, Mitsuoka S, Kawaguchi T, Shintani A. Sawa K, et al. Among authors: kawaguchi t. Clin Lung Cancer. 2024 Mar;25(2):144-150.e3. doi: 10.1016/j.cllc.2023.11.003. Epub 2023 Nov 7. Clin Lung Cancer. 2024. PMID: 38042690

2

A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.

Atagi S, Kawahara M, Hosoe S, Ogawara M, Kawaguchi T, Okishio K, Naka N, Sunami T, Mitsuoka S, Akira M. Atagi S, et al. Among authors: kawaguchi t. Lung Cancer. 2002 Apr;36(1):105-11. doi: 10.1016/s0169-5002(01)00460-3. Lung Cancer. 2002. PMID: 11891041 Clinical Trial.

3

A feasibility study of paclitaxel 225 mg/m(2) and carboplatin AUC = 6 in untreated advanced non-small cell lung cancer patients in Japan.

Ogawara M, Kawahara M, Hosoe S, Atagi S, Kawaguchi T, Okishio K, Naka N, Sunami T, Mitsuoka S, Inoue K, Haryu H, Yoneda T, Origasa H. Ogawara M, et al. Among authors: kawaguchi t. Jpn J Clin Oncol. 2002 Feb;32(2):48-53. doi: 10.1093/jjco/hyf014. Jpn J Clin Oncol. 2002. PMID: 11948228 Clinical Trial.

4

Phase I/II study of docetaxel and S-1 in patients with previously treated non-small cell lung cancer.

Atagi S, Kawahara M, Kusunoki Y, Takada M, Kawaguchi T, Okishio K, Kubo A, Uehira K, Yumine K, Tomizawa Y, Saito R, Fukai S, Komatsu H. Atagi S, et al. Among authors: kawaguchi t. J Thorac Oncol. 2008 Sep;3(9):1012-7. doi: 10.1097/JTO.0b013e318183f8ed. J Thorac Oncol. 2008. PMID: 18758304 Free article. Clinical Trial.

5

Response rate is associated with prolonged survival in patients with advanced non-small cell lung cancer treated with gefitinib or erlotinib.

Tsujino K, Kawaguchi T, Kubo A, Aono N, Nakao K, Koh Y, Tachibana K, Isa S, Takada M, Kurata T. Tsujino K, et al. Among authors: kawaguchi t. J Thorac Oncol. 2009 Aug;4(8):994-1001. doi: 10.1097/JTO.0b013e3181a94a2f. J Thorac Oncol. 2009. PMID: 19633474 Free article.

6

Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.

Kawaguchi T, Takada M, Kubo A, Matsumura A, Fukai S, Tamura A, Saito R, Maruyama Y, Kawahara M, Ignatius Ou SH. Kawaguchi T, et al. J Thorac Oncol. 2010 May;5(5):620-30. doi: 10.1097/JTO.0b013e3181d2dcd9. J Thorac Oncol. 2010. PMID: 20354456 Free article.

7

Small-cell lung cancer in never-smokers: a case series with information on family history of cancer and environmental tobacco smoke.

Kurahara Y, Kawaguchi T, Tachibana K, Atagi S, Hayashi S, Kitaichi M, Ou SH, Takada M. Kurahara Y, et al. Among authors: kawaguchi t. Clin Lung Cancer. 2012 Jan;13(1):75-9. doi: 10.1016/j.cllc.2011.04.001. Epub 2011 May 17. Clin Lung Cancer. 2012. PMID: 21729654 No abstract available.

8

Ethnic difference in hematological toxicity in patients with non-small cell lung cancer treated with chemotherapy: a pooled analysis on Asian versus non-Asian in phase II and III clinical trials.

Hasegawa Y, Kawaguchi T, Kubo A, Ando M, Shiraishi J, Isa S, Tsuji T, Tsujino K, Ou SH, Nakagawa K, Takada M. Hasegawa Y, et al. Among authors: kawaguchi t. J Thorac Oncol. 2011 Nov;6(11):1881-8. doi: 10.1097/JTO.0b013e31822722b6. J Thorac Oncol. 2011. PMID: 21841503 Free article.

9

Chemotherapy is beneficial for elderly patients with advanced non-small-cell lung cancer: analysis of patients aged 70-74, 75-79, and 80 or older in Japan.

Kawaguchi T, Tamiya A, Tamura A, Arao M, Saito R, Matsumura A, Ou SH, Tamura T. Kawaguchi T, et al. Clin Lung Cancer. 2012 Nov;13(6):442-7. doi: 10.1016/j.cllc.2012.03.010. Epub 2012 May 18. Clin Lung Cancer. 2012. PMID: 22609051

10

Prospective assessment of continuation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of pemetrexed.

Yoshimura N, Okishio K, Mitsuoka S, Kimura T, Kawaguchi T, Kobayashi M, Hirashima T, Daga H, Takeda K, Hirata K, Kudoh S. Yoshimura N, et al. Among authors: kawaguchi t. J Thorac Oncol. 2013 Jan;8(1):96-101. doi: 10.1097/JTO.0b013e3182762bfb. J Thorac Oncol. 2013. PMID: 23207920 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,676 results

Search Page

Filters